Evidence map›Paper›PMID 23925390›Full record

ArticleJournal of bone and mineral metabolism2013

A report from Fukushima: an assessment of bone health in an area affected by the Fukushima nuclear plant incident.

Takeaki Ishii, Kazuo Ito, Shigeaki Kato, Masaharu Tsubokura, Sae Ochi, Yukihide Iwamoto, Yasutoshi Saito

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bone and mineral metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Takeaki IshiiDepartment of Orthopaedic Surgery, Soma Central Hospital, 3-5-18 Okinouchi, Soma, Fukushima, 976-0016, Japan, takeaki_ishii@hotmail.co.jp.
Kazuo Ito
Shigeaki Kato
Masaharu Tsubokura
Sae Ochi
Yukihide Iwamoto
Yasutoshi Saito
Soma Central Hospital · JPImperial College London · GBKyushu University · JPSendai Shakai Hoken Hospital · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone health was assessed for inhabitants of an area affected by the Fukushima nuclear plant incident. Osteoporotic patients, who had been treated with active vitamin D3 and/or bisphosphonate at Soma Central Hospital before the Fukushima incident, were enrolled. Changes in bone turnover markers and bone mineral density were retrospectively analyzed. Serum levels of a bone resorption marker, serum type I collagen cross-linked N-telopeptide were decreased in all the treated groups, whereas those of a bone formation marker, bone-specific alkaline phosphatase, were increased. Accordingly, bone mineral density, estimated by dual-energy X-ray absorptiometry, was increased in the lumbar spine of all groups, but bone mass increase in the proximal femur was detected only in the group treated with the two agents in combination. From the degree of these parameter changes, the antiosteoporotic treatments looked effective and were equivalent to the expected potency of past observations. At this stage, the present study implies that the Fukushima nuclear incident did not bring an acute risk to bone health in the affected areas.

Indexed as

Alkaline PhosphataseBiomarkersBone DensityCholecalciferolCollagen Type IFemurFukushima Nuclear AccidentHumansLumbar VertebraeOsteoporosisPeptidesRetrospective StudiesAlkaline PhosphataseBiomarkersCholecalciferolCollagen Type Icollagen type I trimeric cross-linked peptidePeptides

Identifiers

PMID23925390
OpenAlexW1975945980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.